We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+6.16%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$25B
AUM Growth
+$2.37B
Cap. Flow
+$1.17B
Cap. Flow %
4.67%
Top 10 Hldgs %
16.34%
Holding
2,152
New
227
Increased
430
Reduced
632
Closed
714

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$804M
2
ACN icon
Accenture
ACN
+$118M
3
SYY icon
Sysco
SYY
+$76.9M
4
AAPL icon
Apple
AAPL
+$76.7M
5
NTAP icon
NetApp
NTAP
+$69.1M

Sector Composition

Rank Sector Weight
1 Technology 16.58%
2 Healthcare 13.03%
3 Financials 12.46%
4 Consumer Discretionary 10.73%
5 Industrials 9.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VCR icon
576
Vanguard Consumer Discretionary ETF
VCR
$5.92B
$1.82M 0.01%
+10,070
New +$1.78M
UGI icon
577
UGI
UGI
$7.93B
$1.8M 0.01%
32,539
-1,159
-3% -$62.5K
NUS icon
578
Nu Skin
NUS
$249M
$1.8M 0.01%
21,796
+36
+0.2% +$2.86K
MRSH
579
Marsh
MRSH
$87.5B
$1.76M 0.01%
21,340
-800,165
-97% -$67.8M
VFC icon
580
VF Corp
VFC
$6.69B
$1.76M 0.01%
20,045
+12
+0.1% +$1.02K
PLD icon
581
Prologis
PLD
$137B
$1.75M 0.01%
25,775
-34,549
-57% -$2.27M
PX
582
DELISTED
Praxair Inc
PX
$1.74M 0.01%
10,819
-554
-5% -$89K
VSH icon
583
Vishay Intertechnology
VSH
$5.7B
$1.72M 0.01%
84,743
+80,804
+2,051% +$1.9M
WLY icon
584
John Wiley & Sons Class A
WLY
$2.58B
$1.71M 0.01%
+28,200
New +$1.75M
EEP
585
DELISTED
Enbridge Energy Partners
EEP
$1.71M 0.01%
155,320
+10,100
+7% +$114K
PWR icon
586
Quanta Services
PWR
$92.8B
$1.7M 0.01%
51,039
+4,491
+10% +$153K
DISCK
587
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$1.69M 0.01%
+57,117
New +$1.49M
RJF icon
588
Raymond James Financial
RJF
$33.2B
$1.68M 0.01%
27,365
-45,216
-62% -$2.79M
ECL icon
589
Ecolab
ECL
$76.5B
$1.63M 0.01%
10,413
-5,972
-36% -$885K
PXF icon
590
Invesco FTSE RAFI Developed Markets ex-US ETF
PXF
$2.84B
$1.61M 0.01%
+37,160
New +$1.6M
EQM
591
DELISTED
EQM Midstream Partners, LP
EQM
$1.58M 0.01%
29,880
-6,665
-18% -$363K
VIAB
592
DELISTED
Viacom Inc. Class B
VIAB
$1.58M 0.01%
+46,686
New +$1.4M
G icon
593
Genpact
G
$5.48B
$1.57M 0.01%
51,316
+521
+1% +$15.8K
CDK
594
DELISTED
CDK Global, Inc.
CDK
$1.55M 0.01%
24,879
-1,099
-4% -$69.7K
DELL icon
595
Dell
DELL
$275B
$1.55M 0.01%
56,965
-138,746
-71% -$3.7M
BUD icon
596
AB InBev
BUD
$156B
$1.52M 0.01%
17,421
+1,739
+11% +$170K
PRFZ icon
597
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
$2.77B
$1.52M 0.01%
53,515
+1,765
+3% +$50.4K
XLI icon
598
State Street Industrial Select Sector SPDR ETF
XLI
$33.3B
$1.49M 0.01%
19,063
+1,820
+11% +$139K
HEP
599
DELISTED
Holly Energy Partners, L.P.
HEP
$1.49M 0.01%
47,337
-900
-2% -$27.4K
SU icon
600
Suncor Energy
SU
$75.7B
$1.48M 0.01%
38,199
-1,307
-3% -$52.9K

Similar funds

Glenmede Trust's Q3 2018 Portfolio in Review

As of Q3 2018, Glenmede Trust held 2,152 positions worth $25B, up 11% from $22.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Glenmede Trust deployed $1.17B of net new capital in Q3 2018, opening 227 new positions and adding to 430 existing holdings. Its largest new stake was Vanguard Small-Cap ETF: 518,651 shares worth $84.3M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $804M trimmed.

  • Glenmede Trust's largest Q3 2018 buy was Vanguard Small-Cap ETF: 518,651 shares worth $84.3M.
  • Glenmede Trust added most to Alphabet (Google) Class A in Q3 2018, an estimated $783M increase.
  • Glenmede Trust's biggest Q3 2018 reduction was Johnson & Johnson, cutting an estimated $804M.
  • Glenmede Trust fully exited BioTelemetry, Inc. in Q3 2018, selling an estimated $43.4M.
  • Glenmede Trust's ten largest holdings make up 16% of its $25B portfolio in Q3 2018.
  • Glenmede Trust opened 227 new positions and closed 714 in Q3 2018.
  • Glenmede Trust's portfolio value rose 11% quarter-over-quarter to $25B.

Based on Glenmede Trust's 13F filing for Q3 2018, filed 15 Nov 2018.